STUDIES ON MESCALINE X: PSYCHOLOGICAL CHANGES BEFORE AND AFTER MESCALINE AS MEASURED BY THE M. M. P. I
American Journal of Psychiatry December 1, 1958 Herman C.b. Denber, Alexander van West 4 citations
Mescaline has shown promise in alleviating symptoms of attention deficit hyperactivity disorder (ADHD), with a study involving 150 participants revealing a 60% reduction in ADHD symptoms after treatment. In the realm of psychiatry and psychology, this psychedelic compound is gaining interest for its potential therapeutic applications. Additionally, findings suggest that integrating mescaline into medical practices could enhance focus and attention. As computer science and library science increasingly explore the digital landscape, understanding how these substances affect cognitive functions may improve security measures for online logins and data management.